Macrophages as tools and targets in cancer therapy
A Mantovani, P Allavena, F Marchesi… - Nature Reviews Drug …, 2022 - nature.com
Tumour-associated macrophages are an essential component of the tumour
microenvironment and have a role in the orchestration of angiogenesis, extracellular matrix …
microenvironment and have a role in the orchestration of angiogenesis, extracellular matrix …
Overcoming endocrine resistance in breast cancer
Estrogen receptor-positive (ER+) breast cancer is the most common breast cancer subtype.
Treatment of ER+ breast cancer comprises interventions that suppress estrogen production …
Treatment of ER+ breast cancer comprises interventions that suppress estrogen production …
Cancer-associated adipocytes: key players in breast cancer progression
Q Wu, B Li, Z Li, J Li, S Sun, S Sun - Journal of hematology & oncology, 2019 - Springer
Adipocytes are one of the primary stromal cells in many tissues, and they are considered to
play an active role in the tumor microenvironment. Cancer-associated adipocytes (CAAs) …
play an active role in the tumor microenvironment. Cancer-associated adipocytes (CAAs) …
[HTML][HTML] IL6/STAT3 signaling hijacks estrogen receptor α enhancers to drive breast cancer metastasis
R Siersbæk, V Scabia, S Nagarajan, I Chernukhin… - Cancer cell, 2020 - cell.com
Summary The cytokine interleukin-6 (IL6) and its downstream effector STAT3 constitute a
key oncogenic pathway, which has been thought to be functionally connected to estrogen …
key oncogenic pathway, which has been thought to be functionally connected to estrogen …
Endocrine resistance in hormone receptor positive breast cancer–from mechanism to therapy
A Rani, J Stebbing, G Giamas, J Murphy - Frontiers in endocrinology, 2019 - frontiersin.org
The importance and role of the estrogen receptor (ER) pathway has been well-documented
in both breast cancer (BC) development and progression. The treatment of choice in women …
in both breast cancer (BC) development and progression. The treatment of choice in women …
Tumor necrosis factor α blockade: an opportunity to tackle breast cancer
MF Mercogliano, S Bruni, PV Elizalde… - Frontiers in …, 2020 - frontiersin.org
Breast cancer is the most frequently diagnosed cancer and the principal cause of mortality
by malignancy in women and represents a main problem for public health worldwide. Tumor …
by malignancy in women and represents a main problem for public health worldwide. Tumor …
Nuclear receptors: recent drug discovery for cancer therapies
L Zhao, S Zhou, JÅ Gustafsson - Endocrine reviews, 2019 - academic.oup.com
Nuclear receptors (NRs) are transcription factors actively involved in many aspects of human
physiology and pathology, serving as sensors of stimuli, master regulators of downstream …
physiology and pathology, serving as sensors of stimuli, master regulators of downstream …
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
R Siersbæk, S Kumar, JS Carroll - Genes & development, 2018 - genesdev.cshlp.org
Estrogen receptor α (ER) is the major driver of∼ 75% of breast cancers, and multiple ER
targeting drugs are routinely used clinically to treat patients with ER+ breast cancer …
targeting drugs are routinely used clinically to treat patients with ER+ breast cancer …
Crosstalk between estrogen signaling and breast cancer metabolism
E Kulkoyluoglu-Cotul, A Arca… - Trends in Endocrinology & …, 2019 - cell.com
Estrogens and estrogen receptors (ERs) regulate metabolism in both normal physiology and
in disease. The metabolic characteristics of intrinsic breast cancer subtypes change based …
in disease. The metabolic characteristics of intrinsic breast cancer subtypes change based …
The major pre-and postmenopausal estrogens play opposing roles in obesity-driven mammary inflammation and breast cancer development
R Qureshi, M Picon-Ruiz, I Aurrekoetxea-Rodriguez… - Cell Metabolism, 2020 - cell.com
Many inflammation-associated diseases, including cancers, increase in women after
menopause and with obesity. In contrast to anti-inflammatory actions of 17β-estradiol, we …
menopause and with obesity. In contrast to anti-inflammatory actions of 17β-estradiol, we …